The new era of cancer immunotherapy: targeting myeloid-derived suppressor cells to overcome immune evasion

P De Cicco, G Ercolano, A Ianaro - Frontiers in immunology, 2020 - frontiersin.org
Suppression of antitumor immune responses is one of the main mechanisms by which tumor
cells escape from destruction by the immune system. Myeloid-derived suppressor cells …

Meta-analysis of pre-operative magnetic resonance imaging (MRI) and surgical treatment for breast cancer

N Houssami, RM Turner, M Morrow - Breast cancer research and treatment, 2017 - Springer
Background Although there is no consensus on whether pre-operative MRI in women with
breast cancer (BC) benefits surgical treatment, MRI continues to be used pre-operatively in …

Survival study of triple-negative and non–triple-negative breast cancer in a Brazilian cohort

H Gonçalves Jr, MR Guerra… - Clinical Medicine …, 2018 - journals.sagepub.com
Objective: To analyze the clinical, pathological, and sociodemographic aspects between
triple-negative breast cancer (TNBC) and non-TNBC in a Brazilian cohort and identify …

[HTML][HTML] Expression of PD-L1 and prognosis in breast cancer: a meta-analysis

M Zhang, H Sun, S Zhao, Y Wang, H Pu, Q Zhang - Oncotarget, 2017 - ncbi.nlm.nih.gov
The associations between programmed cell death ligand 1 (PD-L1) and the prognosis of
various cancers have always been a research topic of considerable interest. However, the …

Cardiotoxic effects of anthracycline-based therapy: what is the evidence and what are the potential harms?

BE Levis, PF Binkley, CL Shapiro - The Lancet Oncology, 2017 - thelancet.com
Despite the known cardiotoxic effects of doxorubicin and other anthracyclines, no evidence-
based guidelines exist for the surveillance and prevention of chemotherapy-induced …

Naturally-occurring canine mammary tumors as a translational model for human breast cancer

M Gray, J Meehan, C Martínez-Pérez, C Kay… - Frontiers in …, 2020 - frontiersin.org
Despite extensive research over many decades, human breast cancer remains a major
worldwide health concern. Advances in pre-clinical and clinical research has led to …

First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)

CJ Rageth, EAM O'Flynn, C Comstock, C Kurtz… - Breast cancer research …, 2016 - Springer
The purpose of this study is to obtain a consensus for the therapy of B3 lesions. The first
International Consensus Conference on lesions of uncertain malignant potential in the …

Intratumoral spatial heterogeneity at perfusion MR imaging predicts recurrence-free survival in locally advanced breast cancer treated with neoadjuvant chemotherapy

J Wu, G Cao, X Sun, J Lee, DL Rubin, S Napel… - Radiology, 2018 - pubs.rsna.org
Purpose To characterize intratumoral spatial heterogeneity at perfusion magnetic resonance
(MR) imaging and investigate intratumoral heterogeneity as a predictor of recurrence-free …

Blood-based DNA methylation as biomarker for breast cancer: a systematic review

Q Tang, J Cheng, X Cao, H Surowy, B Burwinkel - Clinical epigenetics, 2016 - Springer
Multiple studies have investigated global DNA methylation profiles and gene-specific DNA
methylation in blood-based DNA to develop powerful screening markers for cancer. This …

[HTML][HTML] Interdisciplinary screening, diagnosis, therapy and follow-up of breast cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032 …

A Wöckel, J Festl, T Stüber, K Brust… - Geburtshilfe und …, 2018 - thieme-connect.com
Ziele Das Ziel dieser offiziellen Leitlinie, die von der Deutschen Gesellschaft für
Gynäkologie und Geburtshilfe (DGGG) und der Deutschen Krebsgesellschaft (DKG) …